Metaraminol (Aramine)

Category:

  • Nervous system

Description:

  • Vasopressor

Indications:

  • Acute hypotensive states associated with spinal anesthesia, hemorrhage, reactions to medications, surgical complications

  • Shock associated with brain damage resulting from trauma or tumor

  • “Probably effective” in hypotension due to cardiogenic shock or septicemia

Contraindications:

  • Use with cyclopropane or halothane anesthesia

Precautions:

  • Pregnancy category D

  • Prolonged administration, heart disease, thyroid disease, hypertension, diabetes

  • Cirrhosis, extravasation (phentolamine is antidote), history of malaria

  • Sulfite sensitivity

Adverse Reactions (Side Effects):

  • CNS: apprehension, dizziness, headache, tremors

  • CV: cardiac arrest, flushing, hypertension, hypotension (following cessation), palpitation, sinus tachycardia, ventricular tachycardia, other dysrhymias

  • GI: nausea

  • SKIN: extravasation (abscess, necrosis, sloughing), sweating

Dosage:

Administered subcutaneously, intramuscularly, intravenously

  • Adult:   

    • SC/IM 2-10mg

    • IV INF dilute 15-500mg in 500mg D5W or NS, administer at a rate adjusted to maintain desired blood pressure

    • IV 0.5-5mg as a single dose in severe shock, follow with IV INF

  • Child: 

    • SC/IM 0.1 mg/kg or 3 mg/meter square

    • IV INF 0.4 mg/kg or 12 mg/meter square, diluted and administered at a rate adjusted to maintain desired blood pressure

    • IV 0.01 mg/kg or 0.3 mg/meter square as a single dose in severe shock, follow with IV INF

 

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site